Lv51
1040 积分 2021-02-23 加入
Analytical Procedure Development and Proposed Established Conditions: A Case Study of a Mass Spectrometry Based NDSRI Analytical Procedure
1个月前
已完结
Establishment and application of microbial data deviation investigation and analysis in laboratory
1个月前
已关闭
Pharmaceutical Forced Degradation (Stress Testing) Endpoints: A Scientific Rationale and Industry Perspective
1个月前
已完结
In-situ formation and evaluation of N-nitrosamine drug substance related impurities in glycopeptides implying orbitrap mass spectrometry
1个月前
已完结
Efficient N‐Nitrosation of Sulfonamides with tert‐Butyl Nitrite at Room Temperature
1个月前
已完结
Combating pharmaceutical folklore: No alkyl-sulfonate impurities formed during the synthesis of sulfonate salts
1个月前
已关闭
Precision from drug stability studies. Investigation of reliable repeatability and intermediate precision of HPLC assay procedures
1个月前
已完结
System performance and variability of chromatographic techniques used in pharmaceutical quality control
1个月前
已完结
Is HPLC assay for drug substance a useful quality control attribute?
1个月前
已完结
Quality risk management and data integrity in R&D laboratories supporting CMC lifecycle of biological products
1个月前
已完结
皖公网安备34019202002308
